English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduInvestigators at Cedars-Sinai have identified risk factors that make inflammatory bowel disease (IBD) patients susceptible to developing serious conditions in other parts of their bodies.
Tag: Crohn’s disease
Study to decode microbe-gut signaling suggests potential new treatment for IBD
Fresh insights into how our bodies interact with the microbes living in our guts suggest that a two-drug combination may offer a new way to treat inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.
Low-Dose Naltrexone Shows Promise in Treating Pain in Patients with Fibromyalgia, Crohn’s Disease, Low Back Pain, and Other Chronic Conditions
Naltrexone was originally used to help treat alcohol and opioid abuse. However, at lose doses, naltrexone has been found to help with chronic pain stemming from various conditions including fibromyalgia, Crohn’s disease, diabetic neuropathy, axial low back pain, rheumatoid arthritis, and complex region pain syndrome.
New insights into the mechanisms behind Crohn’s disease point to potential therapeutic target
Mutations within Speckled Protein 140 (SP140) are associated with an increased risk of Crohn’s disease